DNA repair pathways and cisplatin resistance: an intimate relationship

CRR Rocha, MM Silva, A Quinet, JB Cabral-Neto… - Clinics, 2018 - SciELO Brasil
The main goal of chemotherapeutic drugs is to induce massive cell death in tumors.
Cisplatin is an antitumor drug widely used to treat several types of cancer. Despite its …

Translesion and repair DNA polymerases: diverse structure and mechanism

W Yang, Y Gao - Annual review of biochemistry, 2018 - annualreviews.org
The number of DNA polymerases identified in each organism has mushroomed in the past
two decades. Most newly found DNA polymerases specialize in translesion synthesis and …

Mutational signatures are jointly shaped by DNA damage and repair

NV Volkova, B Meier, V González-Huici… - Nature …, 2020 - nature.com
Cells possess an armamentarium of DNA repair pathways to counter DNA damage and
prevent mutation. Here we use C. elegans whole genome sequencing to systematically …

Clonal evolution of chemotherapy-resistant urothelial carcinoma

BM Faltas, D Prandi, ST Tagawa, AM Molina… - Nature …, 2016 - nature.com
Chemotherapy-resistant urothelial carcinoma has no uniformly curative therapy.
Understanding how selective pressure from chemotherapy directs the evolution of urothelial …

Mitotic DNA synthesis in response to replication stress requires the sequential action of DNA polymerases zeta and delta in human cells

W Wu, SA Barwacz, R Bhowmick, K Lundgaard… - Nature …, 2023 - nature.com
Oncogene activation creates DNA replication stress (RS) in cancer cells, which can
generate under-replicated DNA regions (UDRs) that persist until cells enter mitosis. UDRs …

Translesion DNA polymerases in eukaryotes: what makes them tick?

A Vaisman, R Woodgate - Critical reviews in biochemistry and …, 2017 - Taylor & Francis
Life as we know it, simply would not exist without DNA replication. All living organisms utilize
a complex machinery to duplicate their genomes and the central role in this machinery …

Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes

E Pleasance, E Titmuss, L Williamson, H Kwan… - Nature Cancer, 2020 - nature.com
Advanced and metastatic tumors with complex treatment histories drive cancer mortality.
Here we describe the POG570 cohort, a comprehensive whole-genome, transcriptome and …

[HTML][HTML] Spontaneous mutagenesis in human cells is controlled by REV1-Polymerase ζ and PRIMPOL

Z Gyüre, Á Póti, E Németh, B Szikriszt, R Lózsa… - Cell Reports, 2023 - cell.com
Translesion DNA synthesis (TLS) facilitates replication over damaged or difficult-to-replicate
templates by employing specialized DNA polymerases. We investigate the effect on …

A comprehensive survey of the mutagenic impact of common cancer cytotoxics

B Szikriszt, Á Póti, O Pipek, M Krzystanek, N Kanu… - Genome biology, 2016 - Springer
Background Genomic mutations caused by cytotoxic agents used in cancer chemotherapy
may cause secondary malignancies as well as contribute to the evolution of treatment …

Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy

J Anand, L Chiou, C Sciandra, X Zhang, J Hong… - NAR …, 2023 - academic.oup.com
DNA damage tolerance and mutagenesis are hallmarks and enabling characteristics of
neoplastic cells that drive tumorigenesis and allow cancer cells to resist therapy. The 'Y …